滑鼠模型市场分析及预测（至2035年）：依类型、产品类型、服务、技术、应用、组件、最终用户、功能、设备划分

预计小鼠模型市场将从2024年的15亿美元成长到2034年的40亿美元，复合年增长率约为9.5%。小鼠模型市场涵盖基因工程小鼠在生物医学研究中的开发和应用，主要集中在疾病建模、药物发现和安全性测试方面。这些模型为人类疾病的研究提供了重要见解，并推动了个人化医疗和治疗性介入的发展。随着慢性病发病率的上升和对创新治疗方法需求的不断增长，基因编辑技术的进步和研发投入的增加预计将显着推动该市场的成长。

受基因工程技术的进步和临床前研究需求的不断增长的推动，小鼠模型市场正经历强劲增长。基因改造小鼠主导市场，其中基因敲除小鼠和基因转殖小鼠作为关键细分市场表现出色，这主要得益于效用。近交系小鼠紧随其后，因其遗传稳定性和研究可靠性而备受青睐。包括小鼠繁殖和冷冻保存在内的相关服务正在蓬勃发展，为客製化模型的日益普及提供了支持。由于人源化小鼠模型具有提升转化研究成果的潜力，人们对这类模型的兴趣显着增加。此外，先进的表型分析技术也正在兴起，以提高数据准确性和研究效率。随着个人化医疗和标靶治疗的不断发展，对专业小鼠模型的需求预计将持续增长，为市场参与企业带来盈利的机会。注重伦理研究实践和遵守监管规定仍然是实现永续成长的关键。

在小鼠模型市场，市场份额由少数主要企业主导，定价策略也反映了市场对专业化模型的高需求。近期产品推出主要集中在先进的基因改造技术，以满足科学研究应用中对更高精度日益增长的需求。各公司都致力于透过独特的产品和增强的功能来实现差异化，这充分体现了他们对创新的高度重视。小鼠模型在药物研发和生物医学研究中的日益普及进一步加剧了这种竞争格局。竞争基准研究凸显了市场环境的动态性，主要企业都在努力维持自身优势，市场环境也不断变化。监管因素，尤其是在北美和欧洲，透过制定严格的伦理使用和繁殖标准，在塑造市场动态发挥关键作用。这些法规影响市场参与企业的营运策略，并推动合规和创新。该市场拥有大量在研倡议，预示着其健康的成长前景和为相关人员带来的成长机会。

主要趋势和驱动因素：

受基因工程技术的进步以及肿瘤学和免疫学领域研究的不断深入推动，小鼠模型市场正经历强劲增长。其中一个关键趋势是人源化小鼠模型的开发，这对于研究人类特异性疾病和药物反应至关重要。这些模型正成为转化研究的重要工具，弥合了实验室研究结果与临床应用之间的鸿沟。对个人化医疗的需求也是关键驱动因素，推动了对能够模拟个别基因谱的客製化小鼠模型的需求。这一趋势正在加速精准医疗研究，并促成更具针对性和更有效的治疗性介入。此外，受託研究机构（CRO）的兴起使中小型生物技术公司也能更便捷地获得先进的小鼠模型，从而普及了研究能力。同时，伦理考量和法规结构也在重塑市场格局，推动替代方法的发展和现有模型的改进。新兴市场蕴藏着许多机会，这些市场的研究基础设施正在不断完善，生物医学研究投资也持续成长。那些在模型建构方面不断创新并提供全面支援服务的公司，将更有机会在这个不断发展的市场中占据重要份额。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

• 宏观经济分析
• 市场趋势
• 市场驱动因素
• 市场机会
• 市场限制
• 复合年均成长率：成长分析
• 影响分析
• 新兴市场
• 技术蓝图
• 战略框架

第四章 细分市场分析

• 市场规模及预测：依类型
  • 近交系小鼠
  • 基因工程小鼠
  • 条件反射小鼠
  • 非近交系小鼠
  • 混合小鼠
  • 自发突变小鼠
• 市场规模及预测：依产品划分
  • 小鼠模型
  • 小鼠胚胎
  • 滑鼠相关服务
• 市场规模及预测：依服务划分
  • 繁殖服务
  • 冷冻保存
  • 隔离服务
  • 基因检测
• 市场规模及预测：依技术划分
  • CRISPR/Cas9
  • TALENs
  • 锌指核酸酶
• 市场规模及预测：依应用领域划分
  • 肿瘤学
  • 心血管研究
  • 神经科学
  • 免疫学
  • 感染疾病
  • 糖尿病调查
• 市场规模及预测：依组件划分
  • 活鼠
  • 冷冻胚胎
  • 组织样本
• 市场规模及预测：依最终用户划分
  • 製药公司
  • 生技公司
  • 研究所
  • 合约研究机构
• 市场规模及预测：依功能划分
  • 基因表现
  • 表型分析
  • 行为分析
• 市场规模及预测：依设备划分
  • 笼
  • 餵料系统
  • 监测设备

第五章 区域分析

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地区
• 亚太地区
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲
  • 台湾
  • 亚太其他地区
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 义大利
  • 其他欧洲地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非
  • 撒哈拉以南非洲
  • 其他中东和非洲地区

第六章 市场策略

• 需求与供给差距分析
• 贸易和物流限制
• 价格、成本和利润率趋势
• 市场渗透率
• 消费者分析
• 法规概述

第七章 竞争讯息

• 市场定位
• 市场占有率
• 竞争基准
• 主要企业的策略

第八章 公司简介

• The Jackson Laboratory
• Taconic Biosciences
• Charles River Laboratories
• Envigo
• Janvier Labs
• Gen Oway
• Harlan Laboratories
• Horizon Discovery
• Ingenious Targeting Laboratory
• Cyagen Biosciences
• Trans Genic
• Phoenix Bio
• Crown Bioscience
• Ozgene
• Biocytogen
• Shanghai Model Organisms
• Gem Pharmatech
• Vitalstar Biotechnology
• In Vivos
• Yecuris

第九章：关于我们

Mice Model Market is anticipated to expand from $1.5 billion in 2024 to $4.0 billion by 2034, growing at a CAGR of approximately 9.5%. The Mice Model Market encompasses the development and utilization of genetically engineered mice for biomedical research, focusing on disease modeling, drug discovery, and safety testing. These models provide critical insights into human diseases, enabling advancements in personalized medicine and therapeutic interventions. With the rise in chronic diseases and demand for innovative treatments, the market is poised for significant growth, driven by technological advancements in gene editing and increasing investment in R&D.

The Mice Model Market is experiencing robust growth, fueled by advancements in genetic engineering and increasing demand for preclinical research. Genetically modified mice dominate the market, with knockout and transgenic mice being top-performing sub-segments, due to their utility in disease modeling and drug discovery. Inbred mice follow as the second highest performing segment, valued for their genetic consistency and reliability in research studies. The services segment, including breeding and cryopreservation, is gaining momentum, supporting the expanding use of customized models. Rising interest in humanized mice models is notable, driven by their potential to enhance translational research outcomes. Furthermore, the market is witnessing a shift towards advanced phenotyping technologies, improving data accuracy and research efficiency. As personalized medicine and targeted therapies continue to evolve, the demand for specialized mouse models is expected to rise, presenting lucrative opportunities for market participants. The emphasis on ethical research practices and regulatory compliance remains critical to sustainable growth.

In the Mice Model Market, market share is largely dominated by a few key players, with pricing strategies reflecting the high demand for specialized models. Recent product launches have focused on advanced genetic modifications, catering to the growing need for precision in research applications. The emphasis on innovation is evident, as companies strive to differentiate through unique offerings and enhanced capabilities. This competitive landscape is further fueled by the increasing utilization of mice models in drug development and biomedical research. Competition benchmarking reveals a dynamic environment where leading firms are constantly evolving to maintain their edge. Regulatory influences, particularly in North America and Europe, play a pivotal role in shaping market dynamics, setting stringent standards for ethical use and breeding practices. These regulations impact the operational strategies of market participants, driving compliance and innovation. The market is characterized by a robust pipeline of research initiatives, indicating a healthy trajectory of growth and opportunity for stakeholders.

Geographical Overview:

The Mice Model Market is witnessing diverse growth patterns across various regions, each presenting unique opportunities. North America leads the market, driven by advanced research facilities and substantial funding in biomedical research. The region's robust infrastructure for genetic engineering and translational research further propels its dominance. Europe follows, with strong governmental support for healthcare research and increasing demand for personalized medicine. Asia Pacific is experiencing rapid growth, fueled by rising investments in biotechnology and expanding pharmaceutical industries. The region's focus on innovative research and development enhances its market potential. Within this landscape, China and India are emerging as key players, leveraging their vast pools of scientific talent and government initiatives. Latin America and the Middle East & Africa are also gaining traction. In Latin America, growing interest in biopharmaceutical research is evident, while the Middle East & Africa are recognizing the importance of advanced research models to boost healthcare innovation.

The global tariff landscape and geopolitical risks are significantly influencing the Mice Model Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are pivoting towards enhancing domestic research capabilities to mitigate tariff-induced cost pressures on imported laboratory models. China's strategic focus is on self-sufficiency in biomedical research tools amid trade tensions, while Taiwan leverages its advanced biotech sector to maintain competitive advantage. The global market for mice models is thriving, driven by rising demand in biomedical research and drug development. By 2035, the market is poised for robust growth, contingent on geopolitical stability and innovation in genetic engineering. Middle East conflicts could disrupt global supply chains and elevate energy prices, indirectly affecting operational costs and research timelines in this sector.

Key Trends and Drivers:

The Mice Model Market is experiencing robust growth driven by advancements in genetic engineering and increased research in oncology and immunology. A key trend is the development of humanized mice models, which are pivotal for studying human-specific diseases and drug responses. These models are becoming essential tools in translational research, bridging the gap between laboratory findings and clinical applications. The demand for personalized medicine is another significant driver, pushing the need for tailor-made mice models that mimic individual genetic profiles. This trend is accelerating research in precision medicine, enabling more targeted and effective therapeutic interventions. Additionally, the rise of contract research organizations (CROs) is facilitating access to sophisticated mice models for smaller biotech firms, democratizing research capabilities. Moreover, ethical considerations and regulatory frameworks are shaping the market landscape, encouraging the development of alternative methods and refinement of existing models. Opportunities abound in emerging markets where research infrastructure is expanding, and investments in biomedical research are increasing. Companies that innovate in model creation and offer comprehensive support services are well-positioned to capture a significant share of this evolving market.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by Component
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Functionality
• 2.9 Key Market Highlights by Device

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Inbred Mice
  • 4.1.2 Genetically Engineered Mice
  • 4.1.3 Conditioned Mice
  • 4.1.4 Outbred Mice
  • 4.1.5 Hybrid Mice
  • 4.1.6 Spontaneous Mutant Mice
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Mouse Models
  • 4.2.2 Mouse Embryos
  • 4.2.3 Mouse Services
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Breeding Services
  • 4.3.2 Cryopreservation
  • 4.3.3 Quarantine Services
  • 4.3.4 Genetic Testing
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 CRISPR/Cas9
  • 4.4.2 TALENs
  • 4.4.3 Zinc Finger Nucleases
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Oncology
  • 4.5.2 Cardiovascular Studies
  • 4.5.3 Neuroscience
  • 4.5.4 Immunology
  • 4.5.5 Infectious Diseases
  • 4.5.6 Diabetes Research
• 4.6 Market Size & Forecast by Component (2020-2035)
  • 4.6.1 Live Mice
  • 4.6.2 Frozen Embryos
  • 4.6.3 Tissue Samples
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Pharmaceutical Companies
  • 4.7.2 Biotechnology Firms
  • 4.7.3 Research Institutes
  • 4.7.4 Contract Research Organizations
• 4.8 Market Size & Forecast by Functionality (2020-2035)
  • 4.8.1 Gene Expression
  • 4.8.2 Phenotypic Analysis
  • 4.8.3 Behavioral Analysis
• 4.9 Market Size & Forecast by Device (2020-2035)
  • 4.9.1 Cages
  • 4.9.2 Feeding Systems
  • 4.9.3 Monitoring Equipment

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 Component
    • 5.2.1.7 End User
    • 5.2.1.8 Functionality
    • 5.2.1.9 Device
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 Component
    • 5.2.2.7 End User
    • 5.2.2.8 Functionality
    • 5.2.2.9 Device
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 Component
    • 5.2.3.7 End User
    • 5.2.3.8 Functionality
    • 5.2.3.9 Device
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 Component
    • 5.3.1.7 End User
    • 5.3.1.8 Functionality
    • 5.3.1.9 Device
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 Component
    • 5.3.2.7 End User
    • 5.3.2.8 Functionality
    • 5.3.2.9 Device
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 Component
    • 5.3.3.7 End User
    • 5.3.3.8 Functionality
    • 5.3.3.9 Device
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 Component
    • 5.4.1.7 End User
    • 5.4.1.8 Functionality
    • 5.4.1.9 Device
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 Component
    • 5.4.2.7 End User
    • 5.4.2.8 Functionality
    • 5.4.2.9 Device
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 Component
    • 5.4.3.7 End User
    • 5.4.3.8 Functionality
    • 5.4.3.9 Device
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 Component
    • 5.4.4.7 End User
    • 5.4.4.8 Functionality
    • 5.4.4.9 Device
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 Component
    • 5.4.5.7 End User
    • 5.4.5.8 Functionality
    • 5.4.5.9 Device
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 Component
    • 5.4.6.7 End User
    • 5.4.6.8 Functionality
    • 5.4.6.9 Device
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 Component
    • 5.4.7.7 End User
    • 5.4.7.8 Functionality
    • 5.4.7.9 Device
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 Component
    • 5.5.1.7 End User
    • 5.5.1.8 Functionality
    • 5.5.1.9 Device
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 Component
    • 5.5.2.7 End User
    • 5.5.2.8 Functionality
    • 5.5.2.9 Device
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 Component
    • 5.5.3.7 End User
    • 5.5.3.8 Functionality
    • 5.5.3.9 Device
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 Component
    • 5.5.4.7 End User
    • 5.5.4.8 Functionality
    • 5.5.4.9 Device
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 Component
    • 5.5.5.7 End User
    • 5.5.5.8 Functionality
    • 5.5.5.9 Device
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 Component
    • 5.5.6.7 End User
    • 5.5.6.8 Functionality
    • 5.5.6.9 Device
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 Component
    • 5.6.1.7 End User
    • 5.6.1.8 Functionality
    • 5.6.1.9 Device
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 Component
    • 5.6.2.7 End User
    • 5.6.2.8 Functionality
    • 5.6.2.9 Device
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 Component
    • 5.6.3.7 End User
    • 5.6.3.8 Functionality
    • 5.6.3.9 Device
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 Component
    • 5.6.4.7 End User
    • 5.6.4.8 Functionality
    • 5.6.4.9 Device
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 Component
    • 5.6.5.7 End User
    • 5.6.5.8 Functionality
    • 5.6.5.9 Device

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 The Jackson Laboratory
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Taconic Biosciences
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Charles River Laboratories
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Envigo
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Janvier Labs
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Gen Oway
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Harlan Laboratories
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Horizon Discovery
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Ingenious Targeting Laboratory
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Cyagen Biosciences
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Trans Genic
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Phoenix Bio
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Crown Bioscience
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Ozgene
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Biocytogen
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Shanghai Model Organisms
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Gem Pharmatech
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Vitalstar Biotechnology
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 In Vivos
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Yecuris
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us